Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: An analysis from the CAPP2 randomised controlled trial

The Lancet Oncology

Volumn 13, Issue 12, 2012, Pages 1242-1249

  Mathers, John C ^a   Movahedi, Mohammad ^x,y   Macrae, Finlay ^c   Mecklin, Jukka Pekka ^d   Moeslein, Gabriela ^e   Olschwang, Sylviane ^f   Eccles, Diana ^g   Evans, Gareth ^h   Maher, Eamonn R ⁱ   Bertario, Lucio ^j   Bisgaard, Marie Luise ^k   Dunlop, Malcolm ^l   Ho, Judy W C ^m   Hodgson, Shirley ⁿ   Lindblom, Annika ^o   Lubinski, Jan ^p   Morrison, Patrick J ^q   Murday, Victoria ^r   Ramesar, Raj ^s   Side, Lucy ^t   Scott, Rodney J ^u   Thomas, Huw J W ^v   Vasen, Hans ^w   Gerdes, Anne Marie ^a,b   Barker, Gail ^a   Crawford, Gillian ^g   Elliott, Faye ^x   Pylvanainen, Kirsi ^d   Wijnen, Juul ^w   Fodde, Riccardo ^z   Lynch, Henry ^aa   Bishop, D Timothy ^x   Burn, John ^a   more..

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b Clinical Genetics   (Denmark)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

^d JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^e St Josef Hospital   (Germany)

^f INSTITUT PAOLI CALMETTES   (France)

^g UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^h ST MARY S HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^j NATIONAL CANCER INSTITUTE   (Italy)

^k UNIVERSITY OF COPENHAGEN   (Denmark)

^l WESTERN GENERAL HOSPITAL   (United Kingdom)

^m QUEEN MARY HOSPITAL   (Hong Kong)

ⁿ ST GEORGE S HOSPITAL   (United Kingdom)

^o KAROLINSKA INSTITUTE   (Sweden)

^p International Hereditary Cancer Centre   (Poland)

^q QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^r Medical Genetics   (United Kingdom)

^s UNIVERSITY OF CAPE TOWN   (South Africa)

^t CHURCHILL HOSPITAL   (United Kingdom)

^u JOHN HUNTER HOSPITAL   (Australia)

^v ST MARK S HOSPITAL   (United Kingdom)

^w LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^x UNIVERSITY OF LEEDS   (United Kingdom)

^y SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^z ERASMUS MEDICAL CENTER   (Netherlands)

^aa CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO; STARCH;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; DIET SUPPLEMENTATION; DISEASE CARRIER; FEMALE; FOLLOW UP; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; POISSON DISTRIBUTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADULT; AGED; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DIETARY CARBOHYDRATES; DIETARY FIBER; DOUBLE-BLIND METHOD; FEMALE; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; STARCH; YOUNG ADULT;

EID: 84870242223     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(12)70475-8     Document Type: Article

References (32)

1. Marmot M, Atinmo T, Byers T, et al. Food, nutrition, physical activity, and the prevention of cancer: a global perspective: World Cancer Research Fund/American Institute for Cancer Research; 2007.
2. Aune D, Chan DS, Lau R, et al. Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ 2011, 343:d6617.
3. Topping DL, Clifton PM Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 2001, 81:1031-1064.
4. Cassidy A, Bingham SA, Cummings JH Starch intake and colorectal cancer risk: an international comparison. Br J Cancer 1994, 69:937-942.
5. Asp NG, van Amelsvoort JM, Hautvast JG Nutritional implications of resistant starch. Nutr Res Rev 1996, 9:1-31.
6. Clarke JM, Topping DL, Bird AR, Young GP, Cobiac L Effects of high-amylose maize starch and butyrylated high-amylose maize starch on azoxymethane-induced intestinal cancer in rats. Carcinogenesis 2008, 29:2190-2194.
7. Bauer-Marinovic M, Florian S, Müller-Schmehl K, Glatt H, Jacobasch G Dietary resistant starch type 3 prevents tumor induction by 1,2-dimethylhydrazine and alters proliferation, apoptosis and dedifferentiation in rat colon. Carcinogenesis 2006, 27:1849-1859.
8. Williamson SL, Kartheuser A, Coaker J, et al. Intestinal tumorigenesis in the Apc1638N mouse treated with aspirin and resistant starch for up to 5 months. Carcinogenesis 1999, 20:805-810.
9. Williams EA, Coxhead JM, Mathers JC Anti-cancer effects of butyrate: use of micro-array technology to investigate mechanisms. Proc Nutr Soc 2003, 62:107-115.
10. Mathers JC, Smith H, Carter S Dose-response effects of raw potato starch on small-intestinal escape, large-bowel fermentation and gut transit time in the rat. Br J Nutr 1997, 78:1015-1029.
11. Watson AJM An overview of apoptosis and the prevention of colorectal cancer. Crit Rev Oncol Hematol 2006, 57:107-121.
12. Le Leu RK, Brown IL, Hu Y, Morita T, Esterman A, Young GP Effect of dietary resistant starch and protein on colonic fermentation and intestinal tumourigenesis in rats. Carcinogenesis 2007, 28:240-245.
13. Bordonaro M, Lazarova DL, Sartorelli AC Butyrate and Wnt signaling: a possible solution to the puzzle of dietary fiber and colon cancer risk?. Cell Cycle 2008, 7:1178-1183.
14. Dronamraju SS, Coxhead JM, Kelly SB, Mathers JC Differential antineoplastic effects of butyrate in cells with and without a functioning DNA mismatch repair. Nutr Cancer 2010, 62:105-115.
15. van Munster IP, Tangerman A, Nagengast FM Effect of resistant starch on colonic fermentation, bile acid metabolism, and mucosal proliferation. Dig Dis Sci 1994, 39:834-842.
16. Hylla S, Gostner A, Dusel G, et al. Effects of resistant starch on the colon in healthy volunteers: possible implications for cancer prevention. Am J Clin Nutr 1998, 67:136-142.
17. Dronamraju SS, Coxhead JM, Kelly SB, Burn J, Mathers JC Cell kinetics and gene expression changes in colorectal cancer patients given resistant starch: a randomised controlled trial. Gut 2009, 58:413-420.
18. Heijnen ML, van Amelsvoort JM, Deurenberg P, Beynen AC Limited effect of consumption of uncooked (RS2) or retrograded (RS3) resistant starch on putative risk factors for colon cancer in healthy men. Am J Clin Nutr 1998, 67:322-331.
19. Burn J, Bishop DT, Chapman PD, et al. A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis. Cancer Prev Res (Phila) 2011, 4:655-665. and the International CAPP consortium.
20. Burn J, Bishop DT, Mecklin J-P, et al. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. N Engl J Med 2008, 359:2567-2578. and the CAPP2 Investigators.
21. Burn J, Gerdes AM, Macrae F, et al. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet 2011, 378:2081-2087. and the CAPP2 Investigators.
22. Le Leu RK, Hu Y, Brown IL, Young GP Effect of high amylose maize starches on colonic fermentation and apoptotic response to DNA-damage in the colon of rats. Nutr Metab (Lond) 2009, 6:11.
23. Stephen AM, Sieber GM, Gerster YA, Morgan DR Intake of carbohydrate and its components-international comparisons, trends over time, and effects of changing to low-fat diets. Am J Clin Nutr 1995, 62:851S-867S.
24. Vasen HF, Möslein G, Alonso A, et al. Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 2007, 44:353-362.
25. Park Y, Hunter DJ, Spiegelman D, et al. Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA 2005, 294:2849-2857.
26. Bonithon-Kopp C, Kronborg O, Giacosa A, Räth U, Faivre J Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. Lancet 2000, 356:1300-1306. and the European Cancer Prevention Organisation Study Group.
27. Alberts DS, Martínez ME, Roe DJ, et al. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network. N Engl J Med 2000, 342:1156-1162.
28. Schatzkin A, Lanza E, Corle D, et al. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. N Engl J Med 2000, 342:1149-1155. and the Polyp Prevention Trial Study Group.
29. McKeown-Eyssen GE, Bright-See E, Bruce WR, et al. A randomized trial of a low fat high fibre diet in the recurrence of colorectal polyps. J Clin Epidemiol 1994, 47:525-536. and the Toronto Polyp Prevention Group.
30. Lao CD, Brenner DE Strategies for prevention of colorectal cancer: pharmaceutical and nutritional interventions. Curr Treat Options Oncol 2004, 5:417-426.
31. Byers T Diet, colorectal adenomas, and colorectal cancer. N Engl J Med 2000, 342:1206-1207.
32. Goodlad RA, Englyst HN Redefining dietary fibre: potentially a recipe for disaster. Lancet 2001, 358:1833-1834.